Maximus (NYSE:MMS) Upgraded at StockNews.com

Maximus (NYSE:MMSGet Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Thursday.

Maximus Stock Up 3.0 %

Shares of MMS stock traded up $2.13 during trading on Thursday, hitting $72.20. 1,118,699 shares of the company were exchanged, compared to its average volume of 441,236. The business’s 50-day simple moving average is $81.04 and its 200 day simple moving average is $86.20. Maximus has a twelve month low of $69.72 and a twelve month high of $93.97. The firm has a market capitalization of $4.35 billion, a price-to-earnings ratio of 14.44 and a beta of 0.73. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49.

Insider Buying and Selling

In other news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Raymond B. Ruddy acquired 3,490 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 7,063 shares of company stock worth $502,017. Insiders own 1.40% of the company’s stock.

Institutional Trading of Maximus

A number of institutional investors and hedge funds have recently modified their holdings of MMS. Inspire Advisors LLC raised its holdings in Maximus by 1.4% in the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock worth $751,000 after acquiring an additional 121 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in shares of Maximus by 4.5% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after purchasing an additional 136 shares during the period. Petrus Trust Company LTA lifted its position in shares of Maximus by 2.7% during the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock worth $660,000 after purchasing an additional 185 shares during the last quarter. WR Wealth Planners LLC lifted its position in shares of Maximus by 4.6% during the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock worth $388,000 after purchasing an additional 198 shares during the last quarter. Finally, Holocene Advisors LP boosted its stake in Maximus by 6.5% during the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock valued at $366,000 after purchasing an additional 239 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.